Details of the Drug
General Information of Drug (ID: DMCYOPR)
Drug Name |
Anti-CD-20 mab
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Anti-CD-20 mAb (undisclosed indication); Anti-CD-20 mAb (undisclosed indication), PharmAbcine; CD-20 inhibitor (mAb, undisclosed indication), PharmAbcine | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Monoclonal antibody
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||